N-((4aR,4bR,6aR,6bS,8aS,12aS,14bR,16aS)-2,2,4a,6a,6b,11,11,14b-octamethyl-4a,4b,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b,15,16,16a-icosahydro-4H-piceno[3,4-d][1,3]dioxin-8a-yl)-1,4-diazepane-1-carboxamide

ID: ALA4756055

PubChem CID: 162655416

Max Phase: Preclinical

Molecular Formula: C38H63N3O3

Molecular Weight: 609.94

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)CC[C@]2(NC(=O)N3CCCNCC3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@@H]6OC(C)(C)OC[C@@]6(C)[C@@H]5CC[C@]43C)[C@@H]2C1

Standard InChI:  InChI=1S/C38H63N3O3/c1-32(2)16-18-38(40-31(42)41-22-9-20-39-21-23-41)19-17-36(7)26(27(38)24-32)10-11-29-34(5)14-13-30-35(6,25-43-33(3,4)44-30)28(34)12-15-37(29,36)8/h10,27-30,39H,9,11-25H2,1-8H3,(H,40,42)/t27-,28+,29+,30-,34-,35-,36+,37+,38-/m0/s1

Standard InChI Key:  VJZKTIPSMZVEOK-AWCPBGFCSA-N

Molfile:  

 
     RDKit          2D

 48 54  0  0  0  0  0  0  0  0999 V2000
   10.0879  -23.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5035  -23.1434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6801  -23.1389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9192  -21.4959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6385  -21.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0907  -19.4420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5055  -22.3234    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9271  -20.6669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5202  -19.4574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2122  -21.0876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9642  -18.6703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2234  -19.8886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6346  -20.2586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6420  -21.0876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5356  -18.6356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3542  -21.5000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   11.2122  -21.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6742  -17.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7891  -20.6876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2578  -18.2430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8411  -17.5233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5130  -20.2840    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   13.3667  -19.8455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8492  -22.7119    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   14.0740  -21.9227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0736  -21.0963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0654  -20.2669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8030  -19.8624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9235  -22.3247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9354  -20.3008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9422  -19.4937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3613  -20.6718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7807  -21.5127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4921  -21.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3543  -22.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9279  -23.1441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2138  -20.7117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2167  -23.5588    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4952  -21.5016    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   17.6485  -19.8901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3608  -20.3024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6494  -19.0671    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0351  -19.8395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8235  -20.0818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2956  -21.1220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1275  -20.8452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9005  -21.6820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7148  -21.5560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
 32 26  1  0
 17  7  1  0
  9 22  1  1
 10 17  1  0
 32 16  1  6
 28  6  2  0
 29  4  1  1
 26 19  1  0
 20 15  1  0
 29 17  1  0
 32 23  1  0
 37 12  1  0
  6 23  1  0
 18 20  1  0
  9 15  1  0
 12 31  1  0
 20 21  1  0
 14 13  1  1
 31 11  1  0
 19 34  1  0
 12 30  1  1
  5 24  1  6
 29 36  1  0
 14  5  1  0
 14  8  1  0
 34 37  1  0
 28 19  1  0
 35 25  1  0
 26 27  1  1
  9 12  1  0
 19 33  1  6
 38 36  1  0
 29  5  1  0
 10  8  1  0
  5 35  1  0
 25 26  1  0
 11 20  1  0
 28  9  1  0
 14 32  1  0
  7  2  1  0
  2 38  1  0
 17 39  1  6
 30 40  1  0
 40 41  1  0
 40 42  2  0
 41 43  1  0
 43 44  1  0
 41 45  1  0
 44 46  1  0
 45 47  1  0
 46 48  1  0
 47 48  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4756055

    ---

Associated Targets(non-human)

Leishmania mexicana (936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 609.94Molecular Weight (Monoisotopic): 609.4869AlogP: 7.68#Rotatable Bonds: 1
Polar Surface Area: 62.83Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.62CX LogP: 5.64CX LogD: 4.39
Aromatic Rings: Heavy Atoms: 44QED Weighted: 0.30Np Likeness Score: 1.84

References

1. Anderson, Orlagh, Beckett, Joseph, Briggs, Carla C., Natrass, Liam A., Cranston, Charles F., Wilkinson, Elizabeth J., Owen, Jack H., Mir Williams, Rhodri, Loukaidis, Angelos, Bouillon, Marc E., Pritchard, Deiniol, Lahmann, Martina, Baird, Mark S., Denny, Paul W..  (2020)  An investigation of the antileishmanial properties of semi-synthetic saponins,  11  (7): [PMID:33479679] [10.1039/d0md00123f]

Source